Skip to content

TTRX TTRX Prepaid & Other Current

Prepaid & Other Current at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$620.9M+32.4%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$3.46M+44.6%
PTH
Pelthos Therapeutics Inc.PTHS
$2.46M+14,939%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$7.53M-61.2%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$31.98M+39.4%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$26.5M+48.9%

Other financials

Income statement

See full
Operating income-$1.2M-224%
Net income-$971.0K-196%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$11.2M+613%
Total debt$6.0M
Total equity$6.1M+647%
Total assets$18.6M

Cash flow

See full
Operating cash flow-$1.6M-448%

Valuation

See full
Market cap$217.45M-17.7%
Enterprise value$212.24M

Returns & leverage

See full
Return on equity-118.8%
Debt / equity
Current ratio2.2×

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TTRX's prepaid & other current?
TTRX (TTRX) reported prepaid & other current of $235.17K in Q1 2026.
How has TTRX's prepaid & other current changed year-over-year?
TTRX's prepaid & other current decreased by 18.1% year-over-year, from $287.14K to $235.17K.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.